1. Home
  2. MSBI vs VERV Comparison

MSBI vs VERV Comparison

Compare MSBI & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSBI
  • VERV
  • Stock Information
  • Founded
  • MSBI 1881
  • VERV 2018
  • Country
  • MSBI United States
  • VERV United States
  • Employees
  • MSBI N/A
  • VERV N/A
  • Industry
  • MSBI Major Banks
  • VERV Medicinal Chemicals and Botanical Products
  • Sector
  • MSBI Finance
  • VERV Health Care
  • Exchange
  • MSBI Nasdaq
  • VERV Nasdaq
  • Market Cap
  • MSBI 366.8M
  • VERV 384.2M
  • IPO Year
  • MSBI 2016
  • VERV 2021
  • Fundamental
  • Price
  • MSBI $16.42
  • VERV $11.06
  • Analyst Decision
  • MSBI Hold
  • VERV Buy
  • Analyst Count
  • MSBI 3
  • VERV 9
  • Target Price
  • MSBI $21.33
  • VERV $14.75
  • AVG Volume (30 Days)
  • MSBI 142.5K
  • VERV 7.8M
  • Earning Date
  • MSBI 07-24-2025
  • VERV 08-07-2025
  • Dividend Yield
  • MSBI 7.58%
  • VERV N/A
  • EPS Growth
  • MSBI N/A
  • VERV N/A
  • EPS
  • MSBI N/A
  • VERV N/A
  • Revenue
  • MSBI $174,721,000.00
  • VERV $59,613,000.00
  • Revenue This Year
  • MSBI $83.04
  • VERV $27.75
  • Revenue Next Year
  • MSBI $0.85
  • VERV N/A
  • P/E Ratio
  • MSBI N/A
  • VERV N/A
  • Revenue Growth
  • MSBI N/A
  • VERV 271.44
  • 52 Week Low
  • MSBI $14.79
  • VERV $2.87
  • 52 Week High
  • MSBI $28.08
  • VERV $11.41
  • Technical
  • Relative Strength Index (RSI)
  • MSBI 42.01
  • VERV 84.74
  • Support Level
  • MSBI $16.13
  • VERV $5.88
  • Resistance Level
  • MSBI $17.85
  • VERV $11.41
  • Average True Range (ATR)
  • MSBI 0.54
  • VERV 0.49
  • MACD
  • MSBI -0.07
  • VERV 0.64
  • Stochastic Oscillator
  • MSBI 15.70
  • VERV 95.00

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.

Share on Social Networks: